ロード中...
Investigation of cardiovascular protective effect of Shenmai injection by network pharmacology and pharmacological evaluation
BACKGROUND: Shenmai injection (SMI) has been used in the treatment of cardiovascular disease (CVD), such as heart failure, myocardial ischemia and coronary heart disease. It has been found to have efficacy on doxorubicin (DOX)-induced cardiomyopathy. The aims of this study were to explore the underl...
保存先:
| 出版年: | BMC Complement Med Ther |
|---|---|
| 主要な著者: | , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7158159/ https://ncbi.nlm.nih.gov/pubmed/32293408 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12906-020-02905-8 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|